Establishment, Verification and Clinical Application of Chinese Version of Surgical Risk Assessment System
NCT ID: NCT05754268
Last Updated: 2023-03-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
10000 participants
OBSERVATIONAL
2022-01-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Establishment of a Predictive System for Perioperative Risk Assessment and Electronic Flowcharting Response Strategies in Thoracic Surgery
NCT06566053
Digital Early Warning System for Acute Lung Injury in Liver Surgery
NCT07070362
Machine Learning Model to Predict Postoperative Respiratory Failure
NCT04527094
Analysis of Risk Factors and Establishment of Early Warning Model for Pulmonary Complications
NCT04967651
Prevention and Treatment of Perioperative Lung Injury in Elderly Patients
NCT05701449
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Determine the collection index and the complications to be evaluated, and retrospectively collect the preoperative clinical data (including preoperative medical records, examination and examination results) of patients with postoperative complications of gastric and colorectal cancer in our hospital in the past ten years. Preliminary construction of surgical risk assessment system (gastrointestinal surgery)
2. Retrospective or prospective collection of gastric cancer and colorectal surgery cases (not included in the system)
3. The occurrence of postoperative complications was observed until 1 month after discharge. Compare the evaluation results of the system with the actual situation and feedback to further improve the system.
4. The same batch of patient data can be input into NSQIP to re-evaluate and predict the occurrence of patient complications, and then compare the results of the two systems.
5. The incidence of postoperative complications (number of cases and accuracy) of the two groups were counted respectively, and the accuracy and practicability of the evaluation of the two systems were compared to further improve the system.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chinese version of Surgical risk Assessment system Group
This group of patients used the Chinese version of the surgical risk assessment system to evaluate the complications.
Chinese version of the surgical risk assessment system
There is no need to interfere with the patient. Investigators can observe the outcome after using the system for evaluation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Chinese version of the surgical risk assessment system
There is no need to interfere with the patient. Investigators can observe the outcome after using the system for evaluation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Laparotomy or laparoscopic radical resection of gastric or colorectal cancer.
* No postoperative complications such as pneumonia, venous thrombosis, cardiovascular and cerebrovascular accidents occurred before operation.
* There was no serious organ dysfunction before operation.
* Complete auxiliary examination and the availability of examination and examination data were carried out before operation.
Exclusion Criteria
* Unresectable tumors.
* Distant metastasis.
* Severe organ system dysfunction before operation.
* Patients with non-operative treatment.
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
luyun
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
luyun
Chief physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lu Yun, Doctor
Role: STUDY_DIRECTOR
The Affiliated Hospital of Qingdao University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yiheng Ju
Qingdao, Shandong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CSRAS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.